| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.03 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |